The promise of stem cell technologies for treating Parkinson’s disease

The most common PD treatment today is based on enhancing the activity of the nigro-striatal pathway in the brain with dopamine-modulating therapies, thereby increasing striatal dopamine levels and improving motor impairment associated with the disease. Continue reading “The promise of stem cell technologies for treating Parkinson’s disease”

Blog at WordPress.com.

Up ↑